Delcath Systems Inc.
Clinical trials sponsored by Delcath Systems Inc., explained in plain language.
-
New Two-Pronged attack on breast cancer in the liver
Disease control Recruiting nowThis study is testing a two-step treatment for breast cancer that has mainly spread to the liver. Researchers want to see if a high-dose chemotherapy procedure that targets the liver directly, followed by standard cancer drugs, works better and is safer than using the standard dr…
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New Liver-Targeted attack on stubborn colon cancer
Disease control Recruiting nowThis study is for people with advanced colorectal cancer that has spread mainly to the liver and is no longer responding to standard treatments. It aims to see if a procedure that delivers high-dose chemotherapy directly to the liver, followed by standard oral cancer drugs, works…
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC